HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AMSA-OAP protocol

chemotherapy protocol including the above cpds

Also Known As:

AMSA-OAP; VAAP protocol

Networked: 3 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - AMSA-OAP protocol: 3
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - AMSA-OAP protocol: 3
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - AMSA-OAP protocol: 3
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        AMSA-OAP protocol: 3
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - AMSA-OAP protocol: 3
Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienediols
        Prednisone: 12650
        AMSA-OAP protocol: 3

Related Diseases

1.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/01/1990 - "Eighteen adult patients under 55 years of age with acute myelogenous leukemia (AML) who entered remission with induction chemotherapy (AMSA-OAP) received two remission intensification cycles. " 08/01/1994 - "The long-term results in 130 patients with newly diagnosed acute myelogenous leukemia treated with continuous infusion high-dose ara-C (1.5 gm/m2/day x 4 days, CIHDAC) were compared with those in 264 patients treated in previous studies with standard dose ara-C (70-90 mg/m2/d x 7 days) plus either adriamycin (Ad-OAP), or amsacrine (AMSA-OAP). "
2.	Leukemia 05/01/1987 - "It is concluded that AMSA-OAP is equivalent to Ad-OAP in the induction of complete remissions (estimated complete remission rate, 61%) and that assignment of patients to treatment based on predicted prognosis is an ethical and efficient strategy for the evaluation of new therapies in previously untreated patients with acute leukemia."

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	Cytarabine (Cytosar-U)
3.	Amsacrine (AMSA)

Related Therapies and Procedures

1.	Induction Chemotherapy
2.	Therapeutics